“type-1-diabetes” Archives

in
Entry Author Date Location
Viacyte Adds $27M to Move Ahead Trio of Stem Cell Diabetes Treatments 05/26/20 San Diego
Pandion Pulls In $80M as Ulcerative Colitis Drug Advances in Clinic 04/01/20 Boston
Bio Roundup: Clinical Trials Paused, New MS Drug, Kallyope’s Cash & More 03/27/20 National
FDA Rejects Boehringer Ingelheim, Eli Lilly Drug for Type 1 Diabetes 03/23/20 Europe
Biotech Roundup: Novartis on Hold, AMAG Vote, Neuro News & More 11/01/19 National
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone 09/06/19 National
Vertex Bets $950M on Semma and a Stem Cell Therapy for Diabetes 09/03/19 Boston
A Healthier Lifestyle Helped Lead This Tech Exec to His Next Venture 01/22/19 Texas
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More 01/11/19 National
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests 01/09/19 Boston
ViaCyte Raises $80M to Prep for the Clinic Now, Perhaps an IPO Later 11/29/18 San Diego
Amgen Picks Provention to Continue Development of Celiac Disease Drug 11/05/18 New York
CRISPR, ViaCyte Team Up to Develop Stem Cell-Based Diabetes Therapy 09/17/18 San Diego
SQZ Biotech Adds $72M as Cell Therapy Investment Keeps Burning Hot 08/08/18 Boston
Lilly Licenses Sigilon’s Cell Encapsulation Tech for Diabetes Therapy 04/04/18 Boston
Pandion Raises $58M to Bring Cancer-Fighting Tactics to Immune Disorders 01/18/18 Boston
Bio Roundup: Migraine Data, Cancer Drug Combos, Azar Hearing & More 12/01/17 National
With $114M Injection, Semma Continues Quest for Diabetes Cell Therapy 11/30/17 Boston
With $23M, Flagship-Backed Sigilon Protects Protein-Producing Cells 06/21/17 Boston
With Gene Therapy for Diabetes, San Antonio Researcher Eyes Funding 05/31/17 Texas
ViaCyte Raises $10M, Moves to Human Trial with New Diabetes Product 05/23/17 San Diego
ViaCyte Working with Gore to Improve its Synthetic Pancreas Device 03/29/17 San Diego
Arrowhead, Microbes, Diabetes, & More: This Week’s WI Watchlist 11/18/16 Wisconsin
Insulete Co-founder on Hopes, Challenges for Diabetes Gene Therapy 07/15/16 Wisconsin
Retooled Selecta Bio Takes Crossover Cash to IPO Queue 05/24/16 Boston
West Coast Bio Roundup: Tessier-Lavigne, Twist, Unity, Grail & More 02/05/16 San Francisco
ViaCyte Reports on Stem Cell Diabetes Trial, Absorbs BetaLogics 02/04/16 San Diego
Semma Secures $44M to Develop Diabetes Stem Cell Therapy 03/24/15 Boston
West Coast Biotech Roundup: Nevro, Coherus, Xenon, Rock Health, Etc. 11/06/14 San Francisco
West Coast Biotech Roundup: Illumina, Atara, Invitae, Canaan & More 10/17/14 San Francisco
Page 1 of 2 next page »